Daniel Ahlstedt is a biotechnology process engineer with an impressive track record in supporting large capital projects, equipment design, and manufacturing operations while upholding international regulations and FDA requirements. He is currently an MBA candidate at Harvard Business School, where he is sharpening his general management skills to prepare for future leadership positions in the healthcare industry.

Before joining Harvard, Daniel gained valuable insight into the business world and the healthcare industry through various roles at Sanofi Genzyme and State Street Global Advisors. At Sanofi Genzyme, he provided process engineering support to capital projects and manufacturing operations, working his way up from a Process Engineer Co-op to a Process Engineer III. Meanwhile, at State Street Global Advisors, he made valuable contributions as an Assistant Project Manager in Information Technology.

Daniel graduated from Northeastern University, with a B.S. in Chemical Engineering. He is passionate about leveraging his experience and expertise to help his future company achieve its business goals while providing quality healthcare services to the community.